Digital Health Global

NOVEMBER 20, 2023

Drawing on AstraZeneca’s deep experience of developing novel therapeutics and with insights from thousands of patients and clinical researchers, Evinova will provide established technology solutions to pharma, biotech and CROs to support clinical research globally. They can view historic data and forecast future trends.

Life Science 88

Life Science Digital Health Drug Development Patient Experience 88

Healthcare IT Today

NOVEMBER 20, 2022

This article will be a weekly roundup of interesting stories, product announcements, new hires, partnerships, research studies, awards, sales, and more. Spatial released Spatial Space Kit and announced WellStar Hospitals as a customer using immersive sound to help patients and clinical staff relieve stress.

eCare 52

eCare BioTech Primary Care Life Science 52

Healthcare IT Today

JUNE 24, 2022

The following is a guest article by Dr. Neecey Hudson, PhD – Founder & Chief Scientist at Hood Medicine Initiative. Pandemic preparedness has now become a paramount concern across the globe.

Public Health 121

Public Health BioTech Patient Experience Healthcare IT 121

Health Populi

JANUARY 18, 2019

He co-wrote the first “It’s The Prices Stupid” research article in Health Affairs with Gerard Anderson et. First, a Wall Street Journal profile of Bluebird Bio , a biotech firm that plans to sell gene-replacement therapy extending annual payments to patients based on whether the drug is effective.

BioTech 160

BioTech Medicare Medical Billing Patient Experience 160

Health Populi

NOVEMBER 12, 2019

You can read more details about this evolving situation in the WSJ article linked above, and other takes in tech, business, and social media that have begun to populate the interwebs. Was this due to the growing experience and reporting of surprise medical bills? health care.

BioTech 160

BioTech Medical Billing HIPAA Health Information 160

Health Populi

JULY 1, 2019

To address that challenge, in 2017 PLM secured a $100 million (controlling interest) investment from iCarbonX , a Chinese company that is amassing patient data to discover cures for disease. When this occurred, it didn’t cause more than a ripple of interest outside biotech. But the U.S. citizens’ personal data.

Pharmaceuticals 216

Pharmaceuticals HIPAA BioTech Patient Experience 216